Dynavax Technologies | Aktywa



Current Assets Zmiana Data
AbbVie USD 27.68B 2.09B 2025-03
Adma Biologics USD 331.41M 13.22M 2024-12
Amgen USD 26.73B 195M 2025-06
AstraZeneca USD 28.94B 2.8B 2025-06
Biogen USD 7.97B 341.7M 2025-06
BioMarin Pharmaceutical USD 3.81B 337.43M 2025-06
Bristol-Myers Squibb USD 33.22B 2.44B 2025-06
Dynavax Technologies USD 785.71M 30.26M 2025-06
Gilead Sciences USD 14.72B 2.18B 2025-06
Glaxosmithkline GBP 17B 301M 2024-12
Merck USD 37.07B 1.56B 2025-06
Neurocrine Biosciences USD 1.75B 111M 2025-06
Novartis USD 25.94B 831M 2025-06
Pfizer USD 43.7B 2.16B 2025-06
Regeneron Pharmaceuticals USD 16.86B 712.2M 2025-06
Roche Holding CHF 40.04B 6.41B 2024-12
Sarepta Therapeutics USD 2.66B 224.45M 2025-06
TG Therapeutics USD 663.96M 19.45M 2025-06
Vertex Pharmaceuticals USD 10.43B 419.1M 2025-06


Dynavax Technologies Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.